ClinicalTrials.gg
CompletedNCT07705009Updated Jul 15, 2026

Intraoral Scanning Versus Alginate Impressions in Dental Students

An interventional study of Conventional Alginate Impression and TRIOS 3 Intraoral Scanner in Dental Impression Techniques, sponsored by Hue University of Medicine and Pharmacy. Completed at 1 site in Vietnam. Open to participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-15.

Sponsored by Hue University of Medicine and Pharmacy · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled May 2025, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
171
Allocation
Randomized
Ages
18 Years to 24 Years
Sex
All
01

Study summary

Dental impressions are used to create a record of a person's teeth and oral structures. Conventional impressions are made using impression material placed in a tray, whereas digital impressions are obtained using an intraoral scanner.

This randomized clinical trial compared conventional alginate impressions with digital intraoral scanning using the TRIOS 3 and Medit i700 scanners among dental students aged 18 to 24 years. Participants were randomly assigned to one of the three impression techniques. Each participant underwent recording of both the upper and lower dental arches using the assigned technique.

The study primarily compared the chairside time required for each technique and the participants' experience immediately after the procedure. Comfort, nausea, breathing, pain, dry-mouth sensation, perceived procedure speed, overall satisfaction, and preference for conventional or digital impressions were also evaluated.

02

Conditions studied

  • Dental Impression Techniques

Keywords

  • Intraoral Scanning
  • Digital Dental Impression
  • Alginate Impression
  • Procedure Time
  • Patient Comfort
  • Dental Students
03

In context

Lead sponsor

Hue University of Medicine and Pharmacy is the lead sponsor of 13 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergraduate dental students at the University of Medicine and Pharmacy, Hue University.
  • Aged 18 to 24 years.
  • Willing to undergo one maxillary and one mandibular dental impression using the assigned technique.
  • Willing and able to complete the study questionnaire.
  • Provided written .

Exclusion criteria

Exclusion Criteria:

  • Currently undergoing orthodontic treatment.
  • Presence of a systemic disease or acute condition that limited the ability to cooperate or increased the risk of discomfort during impression taking or intraoral scanning, including an acute respiratory disorder or frequent vomiting.
  • Limited mouth opening or an oral and maxillofacial condition that prevented correct impression-tray seating or scanner-tip placement according to the study protocol.
  • A maxillofacial abnormality that markedly affected the procedure or caused significant recording distortion.
  • An excessive gag reflex that prevented completion of the assigned procedure.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
171 participants (actual)

Study arms

  • Active comparator
    Conventional Alginate Impression

    Participants underwent maxillary and mandibular conventional impressions using alginate impression material and stock trays according to the manufacturer's instructions.

    Procedure: Conventional Alginate Impression

  • Experimental
    TRIOS 3 Intraoral Scanning

    Participants underwent full-arch maxillary and mandibular digital impressions and bite registration using the TRIOS 3 intraoral scanner according to the manufacturer's recommended scanning protocol.

    Procedure: TRIOS 3 Intraoral Scanner

  • Experimental
    Medit i700 Intraoral Scanning

    Participants underwent full-arch maxillary and mandibular digital impressions and bite registration using the Medit i700 intraoral scanner according to the manufacturer's recommended scanning protocol.

    Procedure: Medit i700 Intraoral Scanner

Interventions

  • ProcedureConventional Alginate Impression

    Maxillary and mandibular conventional impressions were obtained using Tropical alginate impression material and stock trays. The alginate was mixed, placed in the impression tray, and used according to the manufacturer's instructions.

  • ProcedureTRIOS 3 Intraoral Scanner

    Maxillary and mandibular full-arch digital impressions were obtained using the TRIOS 3 intraoral scanner according to the manufacturer's recommended scanning protocol. A bite-registration scan was also obtained.

  • ProcedureMedit i700 Intraoral Scanner

    Maxillary and mandibular full-arch digital impressions were obtained using the Medit i700 intraoral scanner according to the manufacturer's recommended scanning protocol. A bite-registration scan was also obtained.

06

What researchers measure

Primary outcomes

  1. Total Chairside Procedure Time

    Total chairside procedure time was measured in seconds using a digital stopwatch and calculated as the sum of the recorded procedural stages. For the conventional alginate group, the stages included maxillary mixing, maxillary impression taking, mandibular mixing, and mandibular impression taking. For the digital groups, the stages included patient and case information entry, maxillary scanning, and mandibular scanning. Bite-registration time was excluded from the total procedure time because there was no equivalent stage in the conventional alginate workflow.

    Time frame: During the assigned impression procedure at the single study visit

  2. Patient-Reported Overall Comfort During the Impression Procedure

    Overall comfort during the assigned impression procedure was assessed immediately after the procedure using a 0-to-100 visual analogue scale. Higher scores indicated greater comfort.

    Time frame: Immediately after completion of the assigned impression procedure

07

Study locations

1 site
  • Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University
    Huế, 530000, Vietnam
08

References and documents

Publications

  • Burzynski JA, Firestone AR, Beck FM, Fields HW Jr, Deguchi T. Comparison of digital intraoral scanners and alginate impressions: Time and patient satisfaction. Am J Orthod Dentofacial Orthop. 2018 Apr;153(4):534-541. doi: 10.1016/j.ajodo.2017.08.017. PubMed 29602345 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Aug 2025, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2026
First posted
Jul 15, 2026
StartActual
May 1, 2025
Primary completionActual
Aug 31, 2025
CompletionActual
Aug 31, 2025
Last update
Jul 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07705009
Lead sponsor
Hue University of Medicine and Pharmacy
Responsible party
Le Van Nhat Thang (Principal Investigator, Hue University of Medicine and Pharmacy) — Principal investigator
First posted
Jul 15, 2026
Start date
May 1, 2025
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025
Last update
Jul 15, 2026

Study contacts

Van Nhat Thang Le, DDS PhD
principal investigator · Faculty of Odonto-Stomatology, University of Medicine and Pharmacy, Hue University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion